154 related articles for article (PubMed ID: 38436956)
1. Vascular Endothelial Growth Factor Inhibitors and the Risk of Aortic Aneurysm and Aortic Dissection.
Wu CW; Huang HY; Lin SY; Wang CC; Huang CF; Wu IH
JAMA Netw Open; 2024 Mar; 7(3):e240940. PubMed ID: 38436956
[TBL] [Abstract][Full Text] [Related]
2. Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
Dong YH; Chang CH; Wang JL; Wu LC; Lin JW; Toh S
JAMA Intern Med; 2020 Dec; 180(12):1587-1595. PubMed ID: 32897358
[TBL] [Abstract][Full Text] [Related]
3. Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case-control study.
Son N; Choi E; Chung SY; Han SY; Kim B
BMC Cardiovasc Disord; 2022 Feb; 22(1):44. PubMed ID: 35152888
[TBL] [Abstract][Full Text] [Related]
4. Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
Gopalakrishnan C; Bykov K; Fischer MA; Connolly JG; Gagne JJ; Fralick M
JAMA Intern Med; 2020 Dec; 180(12):1596-1605. PubMed ID: 32897307
[TBL] [Abstract][Full Text] [Related]
5. Persistence and compliance among U.S. patients receiving pazopanib or sunitinib as first-line therapy for advanced renal cell carcinoma: a retrospective claims analysis.
Byfield SA; McPheeters JT; Burton TM; Nagar SP; Hackshaw MD
J Manag Care Spec Pharm; 2015 Jun; 21(6):515-22. PubMed ID: 26011553
[TBL] [Abstract][Full Text] [Related]
6. Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.
Brown JP; Wing K; Leyrat C; Evans SJ; Mansfield KE; Wong AYS; Smeeth L; Galwey NW; Douglas IJ
JAMA Cardiol; 2023 Sep; 8(9):865-870. PubMed ID: 37585175
[TBL] [Abstract][Full Text] [Related]
7. Oral Fluoroquinolone and the Risk of Aortic Dissection.
Lee CC; Lee MG; Hsieh R; Porta L; Lee WC; Lee SH; Chang SS
J Am Coll Cardiol; 2018 Sep; 72(12):1369-1378. PubMed ID: 30213330
[TBL] [Abstract][Full Text] [Related]
8. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
Vogelzang NJ; Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Meiselbach MK; Perez JR; Agarwal N
J Manag Care Spec Pharm; 2018 Jun; 24(6):525-533. PubMed ID: 29799328
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy for metastatic renal cell carcinoma.
Hofmann F; Hwang EC; Lam TB; Bex A; Yuan Y; Marconi LS; Ljungberg B
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012796. PubMed ID: 33058158
[TBL] [Abstract][Full Text] [Related]
10. Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.
Lee CC; Lee MT; Chen YS; Lee SH; Chen YS; Chen SC; Chang SC
JAMA Intern Med; 2015 Nov; 175(11):1839-47. PubMed ID: 26436523
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between fluoroquinolone and aortic aneurysm or dissection.
Huh K; Kang M; Jung J
Eur Heart J; 2023 Nov; 44(42):4476-4484. PubMed ID: 37724037
[TBL] [Abstract][Full Text] [Related]
12. Aneurysm and Artery Dissection After Oral VEGFR-TKI Use in Adults With Cancer.
Kang S; Yeon B; Kim MS; Yoo M; Kim B; Yu YM
JAMA Netw Open; 2023 Nov; 6(11):e2345977. PubMed ID: 38019511
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolones and Risk of Aortic Aneurysm or Dissection in Patients With Congenital Aortic Disease and Marfan Syndrome.
Chen SW; Lin CP; Chan YH; Wu VC; Cheng YT; Tung YC; Hsiao FC; Chen DY; Hung KC; Chou AH; Chu PH
Circ J; 2023 Aug; 87(9):1164-1172. PubMed ID: 36823078
[TBL] [Abstract][Full Text] [Related]
14. Reduced Long-Term Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus: A Nationwide Observational Study.
Avdic T; Franzén S; Zarrouk M; Acosta S; Nilsson P; Gottsäter A; Svensson AM; Gudbjörnsdottir S; Eliasson B
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29367416
[TBL] [Abstract][Full Text] [Related]
15. Association Between Aortic Aneurysm and Aortic Dissection With Fluoroquinolones Use in Patients With Urinary Tract Infections: A Population-Based Cohort Study.
Chen YY; Yang SF; Yeh HW; Yeh YT; Huang JY; Tsao SL; Yeh CB
J Am Heart Assoc; 2022 Mar; 11(6):e023267. PubMed ID: 35229623
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of aortic aneurysm and dissection in patients with Sjögren's syndrome: a nationwide population-based cohort study in Taiwan.
Tsai YD; Chien WC; Tsai SH; Chung CH; Chu SJ; Chen SJ; Liao WI; Yang CJ; Liao MT; Wang JC
BMJ Open; 2018 Sep; 8(9):e022326. PubMed ID: 30244213
[TBL] [Abstract][Full Text] [Related]
17. Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection.
Jun C; Fang B
BMC Cardiovasc Disord; 2021 Sep; 21(1):470. PubMed ID: 34583637
[TBL] [Abstract][Full Text] [Related]
18. Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm.
Chen SW; Chan YH; Chien-Chia Wu V; Cheng YT; Chen DY; Lin CP; Hung KC; Chang SH; Chu PH; Chou AH
J Am Coll Cardiol; 2021 Apr; 77(15):1875-1887. PubMed ID: 33858624
[TBL] [Abstract][Full Text] [Related]
19. Real-World Treatment Patterns and Costs for Patients with Renal Cell Carcinoma Initiating Treatment with Sunitinib and Pazopanib.
MacLean E; Mardekian J; Cisar LA; Hoang CJ; Harnett J
J Manag Care Spec Pharm; 2016 Aug; 22(8):979-90. PubMed ID: 27459661
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent relationship of blood pressure and glycaemic status with risk of aortic dissection and aneurysm.
Suzuki Y; Kaneko H; Yano Y; Okada A; Itoh H; Ueno K; Matsuoka S; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Yokota I; Node K; Yasunaga H; Komuro I
Eur J Prev Cardiol; 2022 Dec; 29(18):2338-2346. PubMed ID: 36082610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
